FGFR4 and neoplasm: At the experimental endpoint, loss of FGFR4 in HPAF-II cell line generated larger tumours with increased number of mitotic figures (Fig. 4E, and data not shown), and significantly increased the metastatic burden at the lungs and the liver (Fig. 4F).